2007•Osteoporosis InternationalRequires access

Effect of raloxifene after recombinant teriparatide [hPTH(1–34)] treatment in postmenopausal women with osteoporosis

S. Adámi, Javier San Martín, Manuel Muñoz‐Torres, Michael J. Econs, Lechun Xie, G. P. Dalsky, Michael R. McClung, Dieter Felsenberg, Jacques P. Brown, Maria Luisa Brandi, Attila Sipos

Open publisher page 82 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 82 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Teriparatide, Raloxifene, Medicine, Osteoporosis, Internal medicine, Rheumatology, Postmenopausal osteoporosis, Endocrinology